We are live on ! Find out more
NRC icon

NRC Health Common Stock

82 hedge funds and large institutions have $242M invested in NRC Health Common Stock in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

25% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 24

6% more funds holding

Funds holding: 7782 (+5)

1.65% more ownership

Funds ownership: 29.28%30.92% (+1.6%)

4% more capital invested

Capital invested by funds: $231M → $242M (+$10.3M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
82
Holders Change
+5
Holders Change %
+6.49%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
30
Reduced
24
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Kayne Anderson Rudnick Investment Management
1
Kayne Anderson Rudnick Investment Management
California
$81.4M +$3.99M +112,364 +5%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$23.2M +$571K +16,096 +3%
BlackRock
3
BlackRock
New York
$17.8M +$93K +2,620 +0.6%
CCA
4
Conestoga Capital Advisors
Pennsylvania
$16.9M +$1.12M +31,505 +7%
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.8M +$1.25M +35,194 +12%
SC
6
Spitfire Capital
California
$11.2M -$336K -9,465 -3%
Renaissance Technologies
7
Renaissance Technologies
New York
$10.8M +$2.2M +61,900 +27%
RA
8
Royce & Associates
New York
$8.39M -$557K -15,677 -7%
State Street
9
State Street
Massachusetts
$6.26M +$253K +7,114 +4%
Northern Trust
10
Northern Trust
Illinois
$5.34M -$349K -9,820 -6%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$3.6M +$5.82K +164 +0.2%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$3.46M +$113K +3,191 +4%
WCM Investment Management
13
WCM Investment Management
California
$2.75M +$24K +676 +0.9%
WA
14
Wasatch Advisors
Utah
$2.73M
Comerica Bank
15
Comerica Bank
Texas
$2.45M +$2.3M +64,827 New
AAMU
16
Amundi Asset Management US
Massachusetts
$1.98M +$1.89M +53,139 New
Ameriprise
17
Ameriprise
Minnesota
$1.93M
MCM
18
McKinley Capital Management
Alaska
$1.79M +$1.1K +31 +0.1%
Neuberger Berman Group
19
Neuberger Berman Group
New York
$1.68M -$505K -14,226 -24%
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$1.63M +$65.7K +1,850 +4%
Charles Schwab
21
Charles Schwab
California
$1.57M +$176K +4,952 +13%
Morgan Stanley
22
Morgan Stanley
New York
$1.56M -$38.9K -1,096 -3%
Bessemer Group
23
Bessemer Group
New Jersey
$1.54M -$125K -3,518 -8%
OSAM
24
O'Shaughnessy Asset Management
Connecticut
$1.41M -$96K -2,704 -7%
CIA
25
Capital Impact Advisors
Massachusetts
$1.34M

NRC Hedge Fund Activity: Q4 2017 in Review

82 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q4 2017, worth a combined $242M — up 4.5% from $231M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NRC positions and 7 closed out — a net gain of 5 holders — while 30 added to existing stakes and 24 trimmed.

The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $3.99M. The largest seller was Royce & Associates, cutting an estimated $557K.

  • 82 institutional investors held NRC Health Common Stock (NRC) as of Q4 2017, up from 77 in Q3 2017.
  • Funds reported $242M of NRC Health Common Stock stock for Q4 2017, up 4.5% quarter-over-quarter.
  • 12 funds opened new NRC Health Common Stock positions in Q4 2017 and 7 closed out, a net change of +5 holders.
  • The largest NRC Health Common Stock buyer in Q4 2017 was Kayne Anderson Rudnick Investment Management, an estimated $3.99M added.
  • The largest NRC Health Common Stock seller in Q4 2017 was Royce & Associates, an estimated $557K sold.

Based on aggregated 13F filings for Q4 2017.